Andrew Le, MD
Dr. Le obtained his MD from Harvard Medical School and his BA from Harvard College. Before Buoy, his research focused on glioblastoma, a deadly form of brain cancer. Outside of work, Dr. Le enjoys cooking and struggling to run up-and-down the floor in an adult basketball league.
Education and training
2010 - 2017 - MD, Harvard Medical School
2006 - 2010 - BA (Economics), Harvard University
Redjal, N., Reinshagen, C., Le, A. et al. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide. J Neurooncol (2016) 127: 505.
Foulds CE, Tsimelzon A, Long W, Le, A., et al. Research resource: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene. Mol Endocrinol. 2010;24(5):1090–1105. doi:10.1210/me.2009-0427
Why We Started Our Health Company
Why We're Coming Out of Stealth Mode
The Future of Healthcare “Using AI and ML to empower people with better insights about their symptoms and help them get to the right care at the right time” with Andrew Le CEO of Buoy Health
Buoy Health Raises $15M in Series B Funding
Buoy Health Partners With Boston Children's Hospital To Improve The Way Parents Currently Assess Their Children's Symptoms Online
Buoy Health partners with CVS Health to provide easy access to affordable care.